You are here

WANTED: Metro Vancouver student for research collaboration on a PCOS related grant application - this request has been filled

The CeMCOR Team is urgently seeking the research collaboration of a Metro Vancouver student (registered at any level of training in BC) to work with us on a grant.

CeMCOR is applying to the Michael Smith Foundation and BC Support Unit for Patient-Oriented Research to study the feasibility of recruitment of local women living with Polycystic Ovary Syndrome (PCOS meaning androgen excess and irregular or far apart periods) to an innovative PCOS therapy. We are proposing, in a different application, to do a 6-month open-label observational study of cyclic progesterone (to “replace” the missing progesterone in a two weeks on and two weeks off way) and spironolactone (an androgen blocking medicine that is safe and effective for unwanted facial hair).

If you are interested please email cemcor.info@ubc.ca

*this request has been filled - thank you for your interest*

Estrogen’s Storm Season: Stories of Perimenopause

Estrogen's Storm Season

by Dr. Jerilynn C Prior

New second edition available

Estrogen’s Storm Season is now available in BOTH print and eBook (Mobi and ePUB) versions!

All royalties support CeMCOR research.

It is full of lively, realistic stories with which women can relate and evidence-based, empowering perimenopause information. It was a finalist in 2006 for the Independent Publisher Book Award in Health.

Purchase your ebook copy via our Amazon Kindle or
Google Play storefronts!

Paperback copies (with updated insert) still available here.

Join a Study:

Get Involved

Volunteer research participants are the heart of all CeMCOR research. Participants are invited to provide feedback on study processes, to learn their own results and at the end of a study, be the first to hear what the whole study found. Please become a CeMCOR research participant—you can contribute to improving the scientific information available for daughters, friends and the wider world of women.